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ABSTRACT  
 
Pancreatic beta cells modulate insulin secretion through rapid sensing of blood glucose 
and integration of gut-derived signals. Increased insulin demand during pregnancy and 
obesity alters islet function and mass, and leads to gestational and type 2 diabetes in 
predisposed individuals. However, it is unclear how blood-borne factors dynamically access 
the islets of Langerhans. Thus, understanding the changes in circulating molecule distribution 
that accompany compensatory beta cell expansion may be key to developing novel anti-
diabetic therapies. Here, using 2-photon microscopy in vivo in mice, we demonstrate that 
islets are almost instantly exposed to peaks of circulating molecules, which rapidly pervade 
the tissue before clearance. In addition, both gestation and short-term high fat diet-feeding 
decrease molecule extravasation and uptake rates in vivo in islets, independently of beta cell 
expansion or islet blood flow velocity. Together, these data support a role for islet vascular 
permeability in shaping beta cell adaptive responses to metabolic demand by modulating the 
access and sensing of circulating molecules. 
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INTRODUCTION 
 
Islets of Langerhans in adult mice are primarily composed of insulin-producing beta 
cells (up to 90%), surrounded by other endocrine cell types [1], and serve to maintain whole 
body glucose homeostasis. Islets are organized in clusters distributed preferentially along 
large blood vessels [2], and the resident endocrine cells are interwoven with a dense capillary 
network. Islet capillaries are denser, more tortuous and more fenestrated than vessels of the 
surrounding exocrine tissue [3]. In addition, relative to their total mass (~1% of the pancreas), 
islets are highly perfused (~10% of pancreatic blood flow) [4, 5]. Both these traits are critical 
to ensure adequate oxygen and nutrient supply, as well as fast-sensing of circulating 
molecules and rapid hormone transport into the blood. Although beta cells integrate a range of 
signals from the circulation involved in insulin secretion and/or beta cell function, survival 
and proliferation (glucagon-like peptide-1 (GLP-1), prolactin/placental lactogen) [6–8], the 
access dynamics of circulating molecules to islets remain largely unexplored.  
 
While adult beta cells are terminally differentiated with low proliferative capacity, 
conditions of increased insulin demand such as pregnancy and obesity can profoundly alter 
beta cell function and/or mass [9]. Failure to compensate for increased insulin demand 
contributes to gestational diabetes and type 2 diabetes (T2D) in genetically-predisposed 
individuals [10]. Beta cell adaption during gestation and high fat diet (HFD) is widely studied 
[11–15], and vessel properties are modified during these highly-proliferative phases. For 
instance, islet blood flow varies during acute and chronic blood glucose concentration 
changes [4, 16–18], insulin resistance states [19], and pregnancy in the rat [20]. Highlighting 
the importance of islet blood flow in beta cell function, ablation of endothelial insulin 
signaling impairs insulin release through effects on the pancreatic blood circulation [21]. 
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However, whether islet vascular permeability is also affected by altered metabolism remains 
uncharacterized. Understanding the changes in molecule access and distribution that 
accompany compensatory beta cell expansion may be key to developing novel anti-diabetic 
therapies/strategies. Therefore, using in vivo imaging approaches, we examined whether 
alterations in islet vascular permeability are associated with beta cell adaptation to both 
physiological and pathological metabolic triggers. 
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RESEARCH DESIGN AND METHODS 
 
Mice and in vivo surgery  
All animal studies were approved by the Languedoc Roussillon Institutional Animal 
Care and Use Committee (CEEA-LR-1053). Virgin or G14.5 gestating 9-12 weeks old female 
C57BL/6J mice were used. All experiments were performed on animals fed ad-libitum. In 
some experiments, virgin RIPTVA-mCherry mice, produced at the National Institute of 
Medical Research, London, were used to facilitate localization of islets. The construct used to 
produce these mice contained 0.7kb RIP  (Rat Insulin Promoter) sequence upstream of TVA-
IRES-mCherry gene, followed by the 3'UTR of the rat prolactin gene (hGH minigene was not 
used) [22, 23], and was micro-injected into the pronucleus of fertilized oocytes of super-
ovulated (CBA/Ca × C57BL/10)F1 mice. RIPTVA-mCherry mice obtained were back-
crossed to C57BL/6J mice for > 8 generations. Mice were either placed on standard diet (SD), 
tryptophan +/- diets (0/0.18% TRP), or high fat diet (63% calories from fat) (Safe Diets). In 
some cases, virgin animals fed 2 weeks with SD were used as controls for G14.5 and 2 weeks 
HFD-fed animals. Intra-peritoneal glucose tolerance tests (IPGTT) and glucose-stimulated 
insulin secretion tests were as described [21, 24]. For in vivo imaging, the pancreas was 
exteriorized by surgery. Animals were anesthetized by injection of ketamine/xylazine 
(0.1/0.02 mg/g), and temperature controlled as described [25, 26]. Respiration was controlled 
by tracheotomy. An incision was made in the peritoneum and the pancreas was gently 
maneuvered onto a custom-made metallic stage covered with a 2 mm-thick layer of soft 
polymer (Bluesil). The pancreas was pinned to the polymer using 4-5 stainless steel minutien 
insect pins (tip = 0.0125 mm). To prevent desiccation, the tissue was superfused with a NaCl 
0.9% heated to 37°C. Imaging commenced 30-40 min post-anesthesia. 
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Measurements of in vivo molecule extravasation rate and diffusion in tissue  
Molecule extravasation was imaged using a multiphoton microscope (Zeiss 7MP) 
adapted with a long-working distance  objective M Plan Apo NIR ×20, 0.4 NA (Mitutoyo), 
and multiphoton excitation and emitted fluorescence collection were as described [26]. 
Surface islets were identified through mCherry localization or by light contrast. FITC- or 
rhodamine-labeled dextrans (Sigma) (25 mg/ml in NaCl 0.9%, 100µl/20 g body weight) were 
injected through a jugular catheter. In some experiments, 100µl/20 g body weight of 50 
mg/ml dextran was used. As this had no effect on measurements, data were pooled. 
Recordings in islets, distinguishable by their tortuous vessels, at depths of 15 to 40 µm below 
the surface, were started at the time of injection, and acquisition rate was set to 3.5 frames/s. 
Regions of interest (ROI) in vessels and in the directly adjacent parenchyma were selected in 
each movie (3-4 µm diameter circles). At least 4 movies from 4 different mice were analyzed 
per molecular weight and condition.  
Tissue movement was corrected using a registration tool based on a subpixel 
translation obtained from a minimal image difference search, as previously described [25, 26]. 
Briefly, movies were imported into ImageJ (NIH) and the average distance of each frame 
calculated versus a reference image over eight trials. A translation was then performed 
corresponding to the minimum of a parabolic interpolation, before application to the entire 
image stack. To obtain the extravasation rate value p (µm/s) for each molecule, an automated 
routine programmed in MATLAB R2011a software was used [26]. This is described 
mathematically as
.Φp+D∆=
t
Φ
∇Φ−
∂
∂
 Φ∇ , corresponding to the fluorescence gradient in 
µm
-1
 and equals 
( ) ( )
l
tΦtΦ outsideinside −
, where outsideinside
ΦΦ −
 is the measured difference 
between fluorescence intensities in the vessel and the parenchyma, and l  is half the distance 
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between the ROIs in µm. D corresponds to the diffusion coefficient in µm
2
/s, p is the 
extravasation rate in µm/s, and D Φ∆  corresponds to the diffusion term. The ascending phase 
of the fluorescence profile obtained experimentally in the vessel ROI was used as input to the 
model. Then, the value of p for which the simulated profile of fluorescence intensity increase 
in the parenchyma over time best fitted experimental values, was selected. The decreasing 
phase of the fluorescence profiles in selected ROIs were modeled using the Nelder-Mead 
Method optimization algorithm, consisting of a decreasing exponential function (MATLAB), 
before calculation of fluorescence decay rates (s
-1
), corresponding to the time constant (1/τ) of 
the exponential fluorescence decay (f(x) = e 
(-t/τ)
).  
 
Measurements of in vivo 2-NBDG uptake rate  
2-NBDG (2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose) (Life 
Technologies) was injected either 5 mg/kg i.v., or 10 mg/kg i.m., in 100 µl, or 40 µl of 0.9% 
NaCl, respectively. Although plasma volume increases during gestation in mice (∼ 26%) [27], 
this is in accordance with a similar increase in weight (∼ 24%), justifying a mg/kg correction. 
Furthermore, uptake rates were unchanged when 2-NBDG was injected above 4 mg/kg i.v. or 
6.25 mg/kg i.m. Vessels were labeled with fluorescent dextran to facilitate islet localization. 
Multiphoton excitation was delivered at 890 nm. Each z plane was scanned every 15s (120 
µm stacks). Movies were stabilized using Huygens Essential (SVI). Fluorescence increase 
over time in ROIs was measured. Following i.v. injection, the first 1.5 min of recordings were 
excluded from analysis, due to contamination of signal by molecules diffusing out of vessels. 
Background fluorescence in exocrine tissue was subtracted from signal measured in islets, and 
fluorescence measurements were normalized. Uptake of 2-NBDG was modeled using either a 
one-phase association curve (i.v), or a variable slope sigmoidal curve (i.m.). First derivatives 
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of the modeled sigmoidal curves were generated using GraphPad Prism. Vmax of derivatives, 
and inflexion points of sigmoidal and one-phase association curves were compared. 
Measurements of red blood cells velocity in vivo  
Blood cells velocity was measured using an epi-fluorescence stereomicroscope 
(StereoDiscovery, Carl Zeiss), as described [25]. Mice were anesthetized using 
ketamine/xylazine (0.1/0.02 mg/g) i.p. Plasma was labeled with FITC-150 kDa dextran. 
Fluorescence emission was captured using an ORCA Flash4.0 sCmos (Hamamatsu). 
Acquisition rate was 150 frames/s, > 1000 frames per movie were captured. Velocities were 
obtained by analyzing diagrams of the intensities along defined capillary paths (in ImageJ 
[25]). Five to 6 mice per condition, and 2-9 islets per mouse were analyzed. 
 
Confocal imaging  
Pancreata were fixed overnight in 4% paraformaldehyde, before head-to-tail slicing on 
a Leica vibratome (100 µm), or snap-frozen in OCT and sectioned using a cryostat (20 µm). 
In some experiments, vessels were filled using gelatin (Sigma) labeled with FITC, through 
intra-cardiac perfusion [25]. Antibody labeling was as described [26]. Images were acquired 
using a Zeiss LSM 780 confocal microscope. Images were analyzed using Imaris (Bitplane), 
Volocity (Perkin Elmer) and ImageJ (NIH).  
For quantifications, one to four slices were randomly selected from at least six 
animals/group, and all islets present analyzed, corresponding to minimum 15 islets/mouse. A 
priori, this is sufficiently-powered to detect a minimum 1.2-fold difference with a SD of 40%, 
a power of 0.9, and alpha = 0.05 (G*Power 3.1). Beta cell proliferation was measured on 
slices stained for Ki67 (rabbit, 1:200, CliniSciences), insulin (guinea-pig, 1:400, Abcam) and 
dapi (Sigma). The proportion of proliferative beta cells was obtained by dividing number of 
Ki67+ nuclei by total number of nuclei of insulin+ cells in islets, as described [14]. Vessel 
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density in z-stack images was assessed by calculating vessel (gelatin-FITC labeled or rat anti-
CD31, 1:100, BD Pharmingen) and islet (insulin+ or mCherry) volume using Volocity (Perkin 
Elmer). To determine beta cell size, pancreas slices were stained for insulin, E-cadherin (rat, 
1:500, Takara) and dapi. The cross-sectional area of E-cadherin insulin-positive cells in which 
a cut nuclei was present was measured using ImageJ (NIH), as described [28].   
 
Electron microscopy 
Pancreata were collected and fixed in 4% paraformaldehyde, 2.5% glutaraldehyde at 
4°C, and sliced on a Leica vibratome. Unlabeled slices were treated as described [29]. Images 
were acquired on a transmission electron microscope (Hitachi H-7100). Density of fenestrae 
per µm was obtained by counting fenestrae on available endothelium of individual vessels 
after subtraction of the perikaryal length. Internal fenestrae diameters and islet vessel lumen 
perimeters in vessels present in cross sections were manually measured using ImageJ (NIH).  
 
Statistical analysis 
Values are represented as means ± SEM, and tests were performed using GraphPad 
Prism. Normality was assessed using D’Agostino-Pearson test. Comparisons were made using 
either unpaired Student’s t-test, or two-tailed Mann-Whitney U-test, as appropriate. Multiple 
comparisons were made using one-way ANOVA followed by Bonferroni’s post-hoc test, or 
two-way ANOVA using Turkey’s multiple comparison test. P values were considered 
significant at P<0.05*, 0.01**, 0.001***.  
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RESULTS 
 
In vivo permeability of vessels in pancreatic islets 
To study molecule access in islets, we developed a novel approach to image the 
pancreas directly in vivo in anesthetized mice, using a 2-photon microscope adapted with long 
working-distance objectives [26] (Fig. 1A-B). Islet localization was initially facilitated by 
using mice on a C57BL/6J background expressing mCherry under the control of the rat 
insulin promoter (RIP) (Fig. S1). As no difference with wild-type C57BL/6J mice were 
observed, data were pooled. Fluorescent-dextran was used for extravasation rate 
measurements, since it avoids artefacts introduced by receptor binding and/or uptake by cells. 
Injection of FITC-labeled dextran (MW <70 kDa) into the jugular vein of virgin animals 
induced a steep increase followed by a rapid decrease in intra-islet fluorescence, suggesting 
that beta cells are only briefly exposed to circulating molecule (Fig. 1C-D, movie S1). 
Extravasation rates from endocrine capillaries were significantly greater than from the 
surrounding exocrine vessels (~5-fold for 4 and 10 kDa molecules and ~10-fold for 20 and 40 
kDa) (Fig. 1E), as expected from the reported differences in fenestration density [3]. In the 
islets, molecules smaller than 70 kDa diffused rapidly across capillaries (Fig. 1E, movie S1). 
By contrast, diffusion of 20 to 40 kDa molecules in the exocrine tissue was very slow, albeit 
detectable.  
In addition to molecule access to pancreatic tissue, we also assessed molecule 
retention in the extracellular space subsequent to entry. To measure this, fluorescence 
exponential decay rates in tissue were calculated. In virgin animals, small molecules (~4 kDa) 
diffused rapidly out of both exocrine and endocrine tissues, whereas for larger molecules (~10 
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kDa), diffusion occurred more slowly out of the exocrine compartment (Fig. 1F). This finding 
supports the notion that endocrine cells only very briefly encounter extravasating molecules.  
 
Islet vessel permeability is modified by metabolic demand  
We next sought to investigate if islet vessel permeability was modified in response to 
changes in metabolic demand. First, gestation was chosen as it represents a normal 
physiological state of insulin resistance accompanied by changes in beta cell proliferation and 
function [11, 30]. As expected, islets from G14.5 animals were 2.5-fold larger than in virgins, 
and this was associated with beta cell hypertrophy/hyper-proliferation, increased basal 
insulinemia, and unchanged glucose-stimulated insulin secretion (Fig. 2A-G, Fig. S2). As 
evidenced by intra-peritoneal glucose tolerance testing (IPGTT), G14.5 mice were glucose 
intolerant (Fig. 2H-I). Second, to determine whether adaptive changes in the islet vasculature 
were specifically associated with pregnancy, or reflected a more generalized response to 
short-term metabolic stress, virgin female mice were fed high fat diet (HFD) for two weeks. 
This paradigm has the advantage of preventing the hormonal changes occurring during 
gestation. As anticipated [13–15], animals fed HFD were heavier and more glucose intolerant 
than their standard chow-fed counterparts, while basal and glucose-stimulated insulin 
secretion were not significantly modified (Fig. 3A-E). Although an increase in islet size could 
not yet be observed at this stage (Fig. 3F-G), beta cells were hypertrophic (Fig. 3H), and an 
increase in beta cell proliferation was evident, as measured by the proportion of Ki67 positive 
beta cells (2-fold increase compared to SD-fed mice) (Fig. 3I-J), and reported in [14]. 
At G14.5, although the general shape of the permeability curve and molecule size cut-
off remained unchanged, molecule extravasation rates from the islet vasculature were 
significantly decreased (Fig. 4A-B, movie S2). This effect was particularly marked for 10 and 
20 kDa molecules and was specific to islets, since no alteration could be detected in exocrine 
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vessels (Fig. 4B). In addition, there was an increase in the rate of molecule diffusion out of 
the endocrine tissue compared to virgin animals (Fig. 4C). Similarly to G14.5, a significant 
decrease in molecule extravasation rate was present in islets of HFD-fed mice, and this was 
more pronounced for smaller molecule sizes (Fig. 4D-E, movie S3). In addition, fluorescence 
decay rates in the endocrine tissue of HFD-fed animals were comparable to those measured at 
G14.5 (Fig. 4F). Decreased retention would shorten the already short-lived peak of molecule 
in the tissue. Thus, beta cells unexpectedly experience less exposure to circulating molecules 
during acute metabolic demand induced by pregnancy and HFD.  
 
Islet structural changes accompanying altered permeability 
Next, to investigate potential mechanisms involved in modifications to islet vessel 
permeability, relevant structural vascular parameters were assessed. At G14.5, there was a 
striking increase in islet volume occupied by capillaries (Fig. 5A), consistent with the reported 
increase in islet endothelial proliferation during gestation [30]. By contrast to the effects of 
long-term high-fat feeding (Fig. S3), and described in [19], changes in vessel density were 
absent following 2 weeks of HFD (Fig. 5B). As an increase in islet vessel volume can result 
from dilation and/or angiogenesis [19], we measured lumen perimeters in cross sections using 
electron microscopy. Mean islet vessel perimeter was significantly increased in gestating 
animals (Fig. 5C-D). While most vessels were a similar size to virgin animals, some appeared 
dilated (Fig. 5D). By contrast, the reported long-term effects of HFD on vessels dilation [19] 
(Fig. S3) were not evident after 2 weeks of treatment (Fig. 5C, E). Fenestration density and 
mean fenestrae diameter remained unchanged between both virgin and G14.5 animals, and 
SD and HFD-fed animals (~75 nm in both cases) (Fig. 5F-K).  
 
Cell proliferation does not modify islet permeability 
Page 13 of 47 Diabetes
14 
 
A common feature of both gestation and HFD treatment is beta cell expansion [14, 
11]. To test whether cell proliferation could drive modifications in vascular permeability, the 
compensatory increases in beta cell mass during gestation were prevented by feeding animals 
from G8.5 to G14.5 with a tryptophan deficient diet (TRP- diet), thereby inhibiting serotonin 
synthesis [31]. Both virgin and gestating mice fed with TRP- diet for 6 days lost weight (Fig. 
6A), but only gestating mice became glucose intolerant (Fig. 6B-C). No increase in islet size 
or beta cell proliferation could be observed at G14.5 compared to virgin animals (Fig. 6D-G), 
as expected [31]. However, extravasation rates of molecules were still reduced in gestating 
animals fed with TRP- diet (Fig. 6H-I and movie S4). Remarkably, in both virgin and G14.5 
TRP- diet-fed mice, values obtained were similar to those of animals fed standard chow, 
despite the absence of gestational increases in islet size. However, islet size distribution and 
beta cell density in islets were altered at G14.5 (Fig. S4A-C), and other changes induced by 
gestation were still present, including beta cell hypertrophy, and increased islet volume 
occupied by vessels (Fig. S4D-F). Fenestrae diameters and density remained unchanged (Fig. 
S4G-H). These findings suggest that changes in islet vessels permeability during gestation are 
independent of beta cell proliferation.  
 
Islet glucose uptake in vivo is decreased in response to metabolic stressors 
Extravasation and retention of molecules may conceivably be modified by binding and 
uptake kinetics, questioning whether islets actually experience ‘lesser exposure’ to circulating 
bioactive molecules. To examine this, glucose uptake was tracked directly in vivo in islets 
using 2-NBDG. This ‘trappable’ fluorescent glucose analog was either injected 
intramuscularly to mimic an increase in molecule concentration in the periphery (e.g. glucose 
release, GLP-1 secretion), or intravenously to control for effects of peripheral glucose 
transport on islet fluorescence accumulation (Fig. 7, movies S5 and S6). Islet fluorescence 
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increase followed sigmoidal or one-phase association curves in response to i.m. (Fig. 7A-B), 
or i.v. injection (Fig. 7C-D), respectively. Comparison of fitted curves versus virgin mice 
revealed, for both injection regimes, reduced 2-NBDG incorporation rates during gestation 
(G14.5) and HFD-feeding, with effects noticeably more pronounced in the latter. Thus, 
metabolic stressors impinge upon substrate uptake, and this occurs in a direction which 
strengthens a role for permeability in islet function through delayed exposure to circulating 
molecules.  
 
Islet blood flow in vivo is unchanged by acute increases in metabolic demand 
 Although the method used to calculate extravasation rate of molecule is independent 
of vascular flow, 2-NBDG binding rate could conceivably be affected by changes in islet 
blood flow velocity. To assess the relative importance of blood flow dynamics, we measured 
red blood cell velocity in vivo, and found that it was comparable in both the endocrine and 
exocrine compartments in virgin, G14.5 and 2 weeks HFD-fed animals (Fig. 8A-B, movie 
S7). Consistent with that previously reported [18], exocrine and islet blood flow under 
hyperglycemia did not significantly differ (Fig. 8B-C). In addition, anesthesia-induced 
hyperglycemia [32] was similar under all conditions examined (Fig. 8C). Thus, delayed 2-
NBDG uptake rate during increased metabolic demand is unlikely to be a consequence of 
reduced islet blood flow. 
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DISCUSSION 
T2D can be described as a failure of beta cells to compensate for peripheral insulin 
resistance, leading to glucose intolerance and health complications [33]. While most studies 
have understandably focused upon impaired beta cell function and insulin receptor signaling, 
the islet microenvironment may provide another route for defective insulin secretion during 
T2D. We therefore aimed to study the access of circulating molecules to islets under normal 
conditions, as well as during both physiological (pregnancy) and pathological (HFD) increased 
metabolic demands. Using in vivo 2-photon microscopy applied to the pancreas of 
anaesthetized mice, we found that beta cells fleetingly encounter circulating molecules, which 
rapidly pervades the tissue before clearance, and that both gestation and short-term HFD (2 
weeks) induce decreases in islet vascular permeability and molecule retention. Vascular 
permeability remained reduced following prevention of gestation-induced beta cell mass 
expansion, suggesting that cell proliferation is unlikely to be a primary driver of islet vascular 
changes. Divergent effects of gestation and 2 weeks HFD were observed on islet vessel 
dilation, suggesting that different mechanisms may be involved in the regulation of 
microenvironment properties. Nonetheless, altered molecule access dynamics and lowered 
exposure to circulating molecule were unifying features of both paradigms. A summary of 
results is presented in Table S1. 
 
The circulation of molecules within the intercellular microenvironment is dependent 
on tissue properties and can greatly influence the sensing of blood-borne signals, in addition 
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to downstream tissue responses [34]. By tracking events in vivo in real-time, we were able to 
determine that circulating molecules (< 70 kDa) could rapidly diffuse through the highly-
fenestrated capillaries of islets, similar to that described in other fenestrated vascular beds in 
vivo [26]. In the pancreas, fenestration density greatly influences molecule extravasation, as 
evidenced by the divergence in rates between exocrine and endocrine tissue, the former 
irrigated by less fenestrated capillaries [3]. Given the density of vascularization in islets, and 
the direct proximity of each beta cell to a vessel, this result strongly suggests that beta cells 
are capable of almost immediately (< 1s) sensing a peak in circulating molecule.  Incidentally, 
beta cells are capable of responding to stimuli delivered over similar time courses [35, 36]. 
This finding has important implications for access of factors secreted in a pulsatile manner in 
distant body compartments and involved in beta cell function and/or insulin secretion (e.g. 
GLP-1, 3.2 kDa; prolactin/placental lactogen, 22 kDa).  
 
By finely regulating the distribution of incoming and outgoing factors through their 
storage/segregation, the tissue microenvironment plays an important role in molecule action. 
For example, various niches which favor cell proliferation have been identified, and this may 
be linked to particular properties of the tissue or presence of growth factors [37, 38]. In virgin 
animals, small molecules such as 4 kDa dextran diffused equally rapidly out of both exocrine 
and endocrine tissues, whereas larger molecules such as 10 kDa dextran diffused more rapidly 
out of the latter, suggesting that islets only perceive ‘flashes’ of circulating molecules and that 
passive retention by the tissue is very limited. Such findings might partly explain why beta 
cells in vivo are less proliferative than some cell types in other tissues, where the 
microenvironment better supports the retention and build-up of mitotic factors [39].  
 
Page 17 of 47 Diabetes
18 
 
Gestation is characterized by beta cell expansion and modifications in beta cell activity 
and hormonal balance [11]. HFD-feeding induces a similar adaptive response, albeit in a 
pregnancy hormone-independent context. Under both conditions, extravasation was 
unexpectedly reduced, suggesting that beta cells experience delayed exposure to circulating 
molecules during heightened insulin demand. This reduced extravasation likely results from a 
decrease in transfer rate of molecules across the vascular membrane, rather than active 
removal from the tissue, i.e. through lymphatic drainage, since lymphatics are rarely 
associated with islets [40]. Moreover, molecule fluorescence profile was modeled in the 
ascending phase, where extravasation rate has more pronounced effects than clearance. 
However, a contribution of the latter to the measures detailed here cannot be ruled out. This 
notwithstanding, alterations to molecule exposure might provide a mechanism to 
downregulate insulin signaling during gestation, helping to maintain the hyperglycemia 
required to support the energy requirements of fetal growth, and may partly explain the 
impaired insulin secretion detected in mice in vivo one week after commencing HFD [13–15], 
despite improved beta cell function in isolated islets [41]. Importantly, this demonstrates that 
molecule diffusion is a dynamic process modulated by physiological state.  
 
Increased islet vessel volume during gestation may be explained by both marked islet 
endothelial proliferation [30] and vessel dilation, as supported by the observed increase in the 
perimeters of a subset of islet vessels at G14.5. By contrast, changes in the islet vasculature 
during long-term HFD treatment depend solely on dilation, and not angiogenesis [19],  
supporting a role for divergent mechanisms in controlling adaptation to metabolic demand. 
We did not observe an increase in islet vessel perimeter after 2 weeks of HFD feeding, 
suggesting that dilation is triggered during later stages of treatment [19]. Although it was 
previously reported that fenestrae density may contribute to the acute regulation of molecule 
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entry into tissues due to their rapid turnover/appearance [3], no change in mean fenestrae 
diameter or density was detected.  We cannot, however, exclude a role for alterations in the 
composition of fenestrae diaphragms, which act as size-selective molecular sieves involved in 
the regulation of basal permeability [42, 43].  
 
It has been shown that the perivascular space can provide a niche for cell proliferation 
[44]. Therefore, it is plausible that beta cell proliferation may directly affect islet capillary 
properties to favor this process. We therefore tested whether inhibition of beta cell 
proliferation during gestation, through suppression of serotonin synthesis [31], was able to 
modify vascular permeability in islets. We found that, besides proliferation, the structural 
changes occurring at G14.5 were unaffected, and permeability in islets was decreased 
compared to virgin mice fed with TRP- diet, possibly through similar mechanisms to 
gestation under normal feeding. Therefore, neither beta cell proliferation nor increased 
serotonin levels appear to be instructive for decreased molecule exposure during gestation, 
despite the reported vasoactive properties of the latter monoamine [45]. Alternative 
mechanisms may include prolactin/placental lactogen, whose circulating levels peak during 
gestation. Both these peptides may regulate vascular plasticity/permeability through signaling 
directly to endothelial cells [46, 47], as well as increasing vascular endothelial growth factor 
production [30]. 
 
The modifications to vascular permeability measured using fluorescent-dextran in vivo 
may not be relevant for biologically-active molecules. Indeed, it could be argued that the 
natural affinity of islets for their substrate may maintain molecule binding/uptake, even in the 
face of altered permeability during metabolic demand. Suggesting that this is not the case, 2-
NBDG uptake rate decreased in islets of gestating animals, despite the reported increase in 
Page 19 of 47 Diabetes
20 
 
GLUT2 expression by G15 [48]. Likewise, 2-NBDG uptake rate was decreased following 
short-term high fat-feeding, probably reflecting changes in membrane-trafficking of GLUT2 
[49]. Although changes in blood flow velocity, generally associated with alterations to 
capillary pressure [50], may affect 2-NBDG uptake rates, we were unable to detect any 
differences in red blood cell velocity in virgin, G14.5 and HFD (2 week)-fed animals. While 
the effects of acutely increased metabolic demand on vascular parameters in awake mice 
remain unknown, and an effect of anaesthetic and/or blood pressure on tissue perfusion 
cannot be completely excluded, this demonstrates that the delayed uptake of 2-NBDG is 
unlikely a consequence of reduced islet blood flow. Thus, the data together suggest that 
vascular permeability likely contributes to islet (patho)physiology by modifying the exposure 
of beta cells to bioactive substances. 
 
In summary, we show that beta cells in vivo are exposed to peaks of circulating 
molecule, and that islet vessel permeability and molecule diffusion are dynamic processes, 
which can be influenced by physiological state. Together with well-characterized molecular 
and cellular mechanisms, the islet vasculature may thus be targeted by T2D insults to 
precipitate insulin secretory failure.  
 
 
 
 
 
 
 
 
Page 20 of 47Diabetes
21 
 
 
 
 
 
 
 
ACKNOWLEDGMENTS 
The authors declare no conflict of interest. Dr. Marie Schaeffer is the guarantor of this 
work and, as such, had full access to all the data in the study and takes responsibility for the 
integrity of the data and the accuracy of the data analysis. DJH, PM and MS designed 
experiments; AM, DJH, AG, GEC, and MS performed experiments; AM, DJH, PF, FM and 
MS analyzed data; CJP, ICR and PLT produced transgenic mice; DJH, PM and MS wrote the 
manuscript. The authors would like to thank C. Lafont and Dr. M. Desarménien, Institute of 
Functional Genomics, Montpellier, for technical assistance with surgery, Dr. C. Cazevieille, 
Centre Régional d’Imagerie Cellulaire, Montpellier, for assistance with the electron 
microscope, Dr. M. Strom, National Institute for Medical Research, London, for help with 
transgenic mouse model production, Dr. X. Bonnefont, Institute of Functional Genomics, 
Montpellier, for useful comments on the manuscript, and all the animal facility staff at the 
Institute of Functional Genomics. Authors were supported by grants from the Agence 
Nationale de la Recherche (ANR BETA-DYN JCJC13 to MS), INSERM, CNRS, University 
of Montpellier, National Biophotonics and Imaging Platform of Ireland (NBIPI), IBiSA, 
Diabetes UK (RD Lawrence Fellowship; 12/0004431 to DJH), Medical Research Council 
(MR/N00275X/1 to DJH), European Foundation for the Study of Diabetes (EFSD/Novo 
Nordisk Rising Star Fellowship to DJH), and Région Languedoc-Roussillon (IPAM).  
 
Page 21 of 47 Diabetes
22 
 
 
 
 
 
 
 
REFERENCES 
1.  Steiner DJ, Kim A, Miller K, Hara M (2010) Pancreatic islet plasticity: interspecies 
comparison of islet architecture and composition. Islets 2:135–145. 
2.  Hara M, Dizon RF, Glick BS, et al. (2006) Imaging pancreatic beta-cells in the intact 
pancreas. Am J Physiol Endocrinol Metab 290:E1041–7. doi: 
10.1152/ajpendo.00365.2005 
3.  Henderson JR, Moss MC (1985) A morphometric study of the endocrine and exocrine 
capillaries of the pancreas. Q J Exp Physiol 70:347–356. 
4.  Jansson L, Hellerstrom C (1983) Stimulation by glucose of the blood flow to the 
pancreatic islets of the rat. Diabetologia 25:45–50. 
5.  Schaeffer M, Hodson DJ, Lafont C, Mollard P (2011) Endocrine cells and blood 
vessels work in tandem to generate hormone pulses. J Mol Endocrinol 47:R59–66. doi: 
10.1530/JME-11-0035 
6.  Campbell JE, Drucker DJ (2013) Pharmacology, physiology, and mechanisms of 
incretin hormone action. Cell Metab 17:819–837. doi: 10.1016/j.cmet.2013.04.008 
7.  Brelje TC, Bhagroo N V, Stout LE, Sorenson RL (2008) Beneficial effects of lipids and 
prolactin on insulin secretion and beta-cell proliferation: a role for lipids in the 
adaptation of islets to pregnancy. J Endocrinol 197:265–276. doi: 10.1677/JOE-07-
0657 
8.  Huang C, Snider F, Cross JC (2009) Prolactin receptor is required for normal glucose 
homeostasis and modulation of beta-cell mass during pregnancy. Endocrinology 
150:1618–1626. doi: 10.1210/en.2008-1003 
9.  Sachdeva MM, Stoffers DA (2009) Minireview: Meeting the demand for insulin: 
molecular mechanisms of adaptive postnatal beta-cell mass expansion. Mol Endocrinol 
23:747–758. doi: 10.1210/me.2008-0400 
Page 22 of 47Diabetes
23 
 
10.  Nolan CJ, Damm P, Prentki M (2011) Type 2 diabetes across generations: from 
pathophysiology to prevention and management. Lancet 378:169–181. doi: 
10.1016/S0140-6736(11)60614-4 
11.  Sorenson RL, Brelje TC (1997) Adaptation of islets of Langerhans to pregnancy: beta-
cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm 
Metab Res 29:301–307. doi: 10.1055/s-2007-979040 
12.  Rieck S, White P, Schug J, et al. (2009) The transcriptional response of the islet to 
pregnancy in mice. Mol Endocrinol 23:1702–1712. doi: 10.1210/me.2009-0144 
13.  Stamateris RE, Sharma RB, Hollern DA, Alonso LC (2013) Adaptive beta-cell 
proliferation increases early in high-fat feeding in mice, concurrent with metabolic 
changes, with induction of islet cyclin D2 expression. Am J Physiol Endocrinol Metab 
305:E149–59. doi: 10.1152/ajpendo.00040.2013 
14.  Mosser RE, Maulis MF, Moullé VS, et al. (2015) High Fat Diet-Induced Beta Cell 
Proliferation Occurs Prior to Insulin Resistance in C57Bl/6J Male Mice. Am J Physiol - 
Endocrinol Metab ajpendo.00460.2014. doi: 10.1152/ajpendo.00460.2014 
15.  Winzell MS, Ahren B (2004) The high-fat diet-fed mouse: a model for studying 
mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 
53 Suppl 3:S215–9. 
16.  Carlsson P-O, Olsson R, Källskog O, et al. (2002) Glucose-induced islet blood flow 
increase in rats: interaction between nervous and metabolic mediators. Am J Physiol 
Endocrinol Metab 283:E457–E464. doi: 10.1152/ajpendo.00044.2002 
17.  Carlsson PO, Andersson A, Jansson L (1998) Influence of age, hyperglycemia, leptin, 
and NPY on islet blood flow in obese-hyperglycemic mice. Am J Physiol 275:E594–
E601. 
18.  Nyman LR, Ford E, Powers AC, Piston DW (2010) Glucose-dependent blood flow 
dynamics in murine pancreatic islets in vivo. Am J Physiol Endocrinol Metab 
298:E807–E814. doi: 10.1152/ajpendo.00715.2009 
19.  Dai C, Brissova M, Reinert RB, et al. (2013) Pancreatic islet vasculature adapts to 
insulin resistance through dilation and not angiogenesis. Diabetes 62:4144–4153. doi: 
10.2337/db12-1657 
20.  Svensson AM, Bodin B, Andersson A, Jansson L (2004) Pancreatic islet blood flow 
during pregnancy in the rat: An increased islet mass is associated with decreased islet 
blood flow. J Endocrinol 180:409–415. doi: 10.1677/joe.0.1800409 
21.  Hashimoto S, Kubota N, Sato H, et al. (2015) Insulin Receptor Substrate-2 (Irs2) in 
Endothelial Cells Plays a Crucial Role in Insulin Secretion. Diabetes 64:876–886. doi: 
10.2337/db14-0432 
Page 23 of 47 Diabetes
24 
 
22.  He Z, Fernandez-Fuente M, Strom M, et al. (2011) Continuous on-line monitoring of 
secretion from rodent pituitary endocrine cells using fluorescent protein surrogate 
markers. J Neuroendocr 23:197–207. doi: 10.1111/j.1365-2826.2010.02104.x 
23.  Bates P, Young JA, Varmus HE (1993) A receptor for subgroup A Rous sarcoma virus 
is related to the low density lipoprotein receptor. Cell 74:1043–1051. 
24.  Lemaire K, Ravier MA, Schraenen A, et al. (2009) Insulin crystallization depends on 
zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in 
mice. Proc Natl Acad Sci U S A 106:14872–14877. doi: 10.1073/pnas.0906587106 
25.  Lafont C, Desarmenien MG, Cassou M, et al. (2010) Cellular in vivo imaging reveals 
coordinated regulation of pituitary microcirculation and GH cell network function. Proc 
Natl Acad Sci U S A 107:4465–4470. doi: 10.1073/pnas.0902599107 
26.  Schaeffer M, Langlet F, Lafont C, et al. (2013) Rapid sensing of circulating ghrelin by 
hypothalamic appetite-modifying neurons. Proc Natl Acad Sci U S A 110:1512–1517. 
doi: 10.1073/pnas.1212137110 
27.  Kulandavelu S, Qu D, Adamson SL (2006) Cardiovascular function in mice during 
normal pregnancy and in the absence of endothelial NO synthase. Hypertension 
47:1175–1182. doi: 10.1161/01.HYP.0000218440.71846.db 
28.  Sun G, Tarasov AI, McGinty JA, et al. (2010) LKB1 deletion with the RIP2.Cre 
transgene modifies pancreatic beta-cell morphology and enhances insulin secretion in 
vivo. Am J Physiol Endocrinol Metab 298:E1261–73. doi: 
10.1152/ajpendo.00100.2010 
29.  Guillou A, Romanò N, Bonnefont X, et al. (2011) Modulation of the tyrosine kinase 
receptor ret/glial cell-derived neurotrophic factor (GDNF) signaling: A new player in 
reproduction induced anterior pituitary plasticity? Endocrinology 152:515–525. doi: 
10.1210/en.2010-0673 
30.  Johansson M, Mattsson G, Andersson A, et al. (2006) Islet endothelial cells and 
pancreatic beta-cell proliferation: studies in vitro and during pregnancy in adult rats. 
Endocrinology 147:2315–2324. doi: 10.1210/en.2005-0997 
31.  Kim H, Toyofuku Y, Lynn FC, et al. (2010) Serotonin regulates pancreatic beta cell 
mass during pregnancy. Nat Med 16:804–808. doi: 10.1038/nm.2173 
32.  Saha JK, Xia J, Grondin JM, et al. (2005) Acute hyperglycemia induced by 
ketamine/xylazine anesthesia in rats: mechanisms and implications for preclinical 
models. Exp Biol Med (Maywood) 230:777–784. doi: 230/10/777 [pii] 
33.  Forbes JM, Cooper ME (2013) Mechanisms of diabetic complications. Physiol Rev 
93:137–88. doi: 10.1152/physrev.00045.2011 
34.  Richards OC, Raines SM, Attie AD (2010) The role of blood vessels, endothelial cells, 
and vascular pericytes in insulin secretion and peripheral insulin action. Endocr Rev 
31:343–363. doi: 10.1210/er.2009-0035 
Page 24 of 47Diabetes
25 
 
35.  Reinbothe TM, Safi F, Axelsson AS, et al. (2014) Optogenetic control of insulin 
secretion in intact pancreatic islets with β-cell-specific expression of 
Channelrhodopsin-2. Islets. doi: 10.4161/isl.28095 
36.  Tarasov AI, Semplici F, Ravier MA, et al. (2012) The mitochondrial Ca2+ uniporter 
MCU is essential for glucose-induced atp increases in pancreatic ??-cells. PLoS One. 
doi: 10.1371/journal.pone.0039722 
37.  Kokovay E, Goderie S, Wang Y, et al. (2010) Adult SVZ lineage cells home to and 
leave the vascular niche via differential responses to SDF1/CXCR4 signaling. Cell 
Stem Cell 7:163–173. doi: 10.1016/j.stem.2010.05.019 
38.  Charles N, Holland EC (2010) The perivascular niche microenvironment in brain 
tumor progression. Cell Cycle 9:3012–3021. doi: 10.4161/cc.9.15.12710 
39.  Morrison SJ, Scadden DT (2014) The bone marrow niche for haematopoietic stem 
cells. Nature 505:327–34. doi: 10.1038/nature12984 
40.  O’Morchoe CCC (1997) Lymphatic system of the pancreas. Microsc Res Tech 37:456–
477. doi: 10.1002/(SICI)1097-0029(19970601)37:5/6<456::AID-JEMT9>3.0.CO;2-B 
41.  Collins SC, Hoppa MB, Walker JN, et al. (2010) Progression of diet-induced diabetes 
in C57BL6J mice involves functional dissociation of Ca2(+) channels from secretory 
vesicles. Diabetes 59:1192–1201. doi: 10.2337/db09-0791 
42.  Stan R V., Tse D, Deharvengt SJ, et al. (2012) The Diaphragms of Fenestrated 
Endothelia: Gatekeepers of Vascular Permeability and Blood Composition. Dev Cell 
23:1203–1218. doi: 10.1016/j.devcel.2012.11.003 
43.  Deharvengt SJ, Tse D, Sideleva O, et al. (2012) PV1 down-regulation via shRNA 
inhibits the growth of pancreatic adenocarcinoma xenografts. J Cell Mol Med 16:2690–
2700. doi: 10.1111/j.1582-4934.2012.01587.x 
44.  Eberhard D, Kragl M, Lammert E (2010) “Giving and taking”: endothelial and beta-
cells in the islets of Langerhans. Trends Endocrinol Metab 21:457–463. doi: 
10.1016/j.tem.2010.03.003 
45.  Colditz IG (1991) The induction of plasma leakage in skin by histamine, bradykinin, 
activated complement, platelet-activating factor and serotonin. Immunol Cell Biol 69 ( 
Pt 3):215–219. doi: 10.1038/icb.1991.31 
46.  Merkle CJ, Schuler LA, Schaeffer RC, et al. (2000) Structural and functional effects of 
high prolactin levels on injured endothelial cells: evidence for an endothelial prolactin 
receptor. Endocrine 13:37–46. doi: 10.1385/ENDO:13:1:37 
47.  Kolonin MG, Sun J, Do KA, et al. (2006) Synchronous selection of homing peptides 
for multiple tissues by in vivo phage display. Faseb J 20:979–981. doi: 10.1096/fj.05-
5186fje 
Page 25 of 47 Diabetes
26 
 
48.  Weinhaus AJ, Stout LE, Sorenson RL (1996) Glucokinase, hexokinase, glucose 
transporter 2, and glucose metabolism in islets during pregnancy and prolactin-treated 
islets in vitro: Mechanisms for long term up-regulation of islets. Endocrinology 
137:1640–1649. doi: 10.1210/en.137.5.1640 
49.  Reimer MK, Ahrén B (2002) Altered β-cell distribution of pdx-1 and GLUT-2 after a 
short-term challenge with a high-fat diet in C57BL/6J mice. Diabetes. doi: 
10.2337/diabetes.51.2007.S138 
50.  Carlsson PO, Jansson L, Andersson A, Kallskog O (1998) Capillary blood pressure in 
syngeneic rat islets transplanted under the renal capsule is similar to that of the 
implantation organ . Diabetes 47:1586–1593.  
 
 
FIGURES LEGENDS 
 
Figure 1. In vivo molecule diffusion and extravasation in islets. V: Virgin. A-B) Schematic 
representation of the imaging setup: side view (A), ventral view (B). 1: tracheotomy, 2: 
jugular catheter, 3: heated saline perfusion, 4: temperature control. C) Fluorescence variation 
at three time points after i.v. injection of 4 kDa fluorescent dextran, in the exocrine tissue 
(top), and in islets (bottom; dashed circle) (Scale: 100 µm). Tmax corresponds to time at 
which fluorescence intensity is maximum in the vessels. Green: FITC. Fluorescence 
variations were measured in regions of interest (blue and red dots). See also Movie S1. D) 
Fluorescence intensity profiles over time post-injection of 4 kDa fluorescent dextran (AU) in 
vessels (red lines) and parenchyma (blue lines) of the endocrine (left) and exocrine (right) 
tissues. Lines correspond to times points at which pictures in (C) were taken. E) Molecule 
extravasation rate as a function of MW (n = 4-8 mice per condition; 1-2 movies/mouse). F) 
Fluorescence decrease rate measured in tissue parenchyma, as a function of MW (n = 4-8 
mice per condition; 1-2 movies/mouse, one-way ANOVA). Values represent mean ± SEM. 
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Figure 2. Islet and beta cell modifications at G14.5 of gestation. A) Representative 
confocal images of islets in virgin animals and at G14.5 (scale bar: 50 µm, Z-projection of 16 
µm stacks). B) Islet size is increased at G14.5 (n = 6 animals per condition; P<0.0005 Mann-
Whitney test). C) Beta cells are hypertrophic at G14.5 (n = 6 animals per condition; P<0.001 
Mann-Whitney test). D-E) Basal insulin level is increased (n = 4-5 mice per condition, P<0.05 
Mann-Whitney test), while glucose-stimulated insulin secretion is unchanged at G14.5, as 
assessed by measurement of the increase in plasma insulin concentration post-glucose 
injection (3 g/kg) (e) (n = 4-5 mice per condition, two-way ANOVA). F) Representative 
confocal images of Ki67 labeling in virgin animals and at G14.5 (same islets as in A) (scale 
bar: 50 µm, Z-projection of 16 µm stacks). G) Proliferation is increased at G14.5 (n = 6 
animals per condition; P<0.001 Mann-Whitney test). H-I) IPGTT (2g/kg) in virgin and at 
G14.5 (H), and area under the curve (AUC) analysis (I) shows glucose intolerance at G14.5 (n 
= 6-8 animals per condition, P<0.01 Mann-Whitney test). Values represent mean ± SEM. 
 
Figure 3. Glucose metabolism and beta cell proliferation are altered by 2 weeks of high 
fat diet. SD: standard diet, HFD: high fat diet. A) Body weight increase was larger in mice 
fed HFD (n = 18 mice per condition; two-way ANOVA). B) Randomly fed blood glucose 
levels were higher in HFD fed mice (n = 30 mice per condition; two-way ANOVA). C-D) 
IPGTT (2g/kg) in SD and HFD fed animals (C), and area under the curve (AUC) analysis (D) 
shows glucose intolerance (n = 11 animals per condition, P<0.01 Mann-Whitney test). E) 
Glucose-stimulated insulin secretion (3 g/kg) is not significantly decreased by 2 weeks HFD 
(n = 5 mice per condition, two-way ANOVA). F) Representative confocal images of islets in 
animals fed standard chow (SD) or HFD for 2 weeks (scale bar: 100 µm, Z-projection of 16 
µm stacks). G) Islet size is not modified (n = 6 animals, 40-80 islets per condition; one-way 
ANOVA). H) Beta cells are hypertrophic at HFD 2 weeks (n = 6 animals per condition; 
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P<0.001 Mann-Whitney test). I) Representative confocal images of Ki67 labeling in SD or 
HFD fed animals (scale bar: 100 µm, Z-projection of 16 µm stacks). J) Proliferation is 
increased following 2 weeks HFD feeding (n = 6 animals per condition; one-way ANOVA). 
Values represent mean ± SEM. 
 
Figure 4. Modification of molecule diffusion in islets during metabolic demand. V: 
Virgin. HFD2w: High-fat-diet 2 weeks. A) Fluorescence variation in an islet (dashed circle) at 
three time points after i.v. injection of 4 kDa dextran at G14.5 of gestation (see also Movie 
S2) (Scale: 100 µm). Tmax corresponds to time at which fluorescence intensity is maximum 
in the vessels. Green: FITC. Fluorescence variations were measured in regions of interest 
(blue dots). Comparable images in virgin animals can be found in Fig. 1C. B) Molecule 
extravasation rate as a function of MW (n = 4-8 mice per condition; 1-2 movies/mouse) at 
G14.5. C) Fluorescence decrease rate in tissue parenchyma, as a function of MW at G14.5 (n 
= 4-9 mice per condition; 1-2 movies/mouse; one-way ANOVA). D) Fluorescence variation 
in an islet (dashed circle) at three time points after i.v. injection of 4 kDa dextran following 2 
weeks of HFD (see also Movie S3) (Scale: 100µm). Green: FITC. Fluorescence variations 
were measured in regions of interest (blue dots). E) Molecule extravasation rate as a function 
of molecular weight (n = 4-8 mice per condition; 1-2 movies/mouse) following 2 weeks of 
HFD. F) Fluorescence decrease rate in tissue parenchyma as a function of molecular weight (n 
= 4-9 mice per condition; 1-2 movies/mouse; one-way ANOVA) following 2 weeks of HFD. 
Values represent mean ± SEM. 
 
Figure 5. Alterations to vessels in response to gestation and HFD. SD: standard diet, HFD: 
high fat diet. V: virgin. Values represent mean ± SEM. A-B) Representative confocal images 
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of islet vasculature in virgin and gestating (G14.5) animals (A, left), and SD and HFD fed 
animals (B, left) (scale: 10 µm). Z-projections of 26 (A) or 15 (B) µm stacks. Percentage of 
islet volume occupied by vessels (A-B, right panels) (n = 6 mice, 3-10 islets per mouse; 
P<0.01 (A) and P = 0.19 (B); Student t-test). C) Representative transmission electron 
microscopy (TEM) images of islet vessels from virgin, G14.5 and HFD 2 weeks animals 
(scale: 10 µm). D) Islet vessels lumen perimeter is increased at G14.5 compared to virgin 
animals (n = 2 mice, 14-17 vessels per condition, P<0.01, Student t-test). E) Islet vessel lumen 
perimeter is unchanged in HFD 2 weeks compared to standard fed animals (n = 2 mice, 17-25 
vessels per condition, P=0.11, Student t-test). F) Representative TEM images of islet vessels 
in virgin and G14.5 animals (scale: 1 µm). Boxed areas (left) are enlarged (right). Arrows 
indicate fenestrations. G) Density of fenestrations per µm of endothelium shows no variation 
between virgin and G14.5 (n = 2 mice per condition, 20-48 µm endothelium; P=0.2854 
Student t-test). H) Density of fenestrations is unchanged by HFD 2 weeks (n = 2 mice per 
condition, 25-48 µm endothelium; P = 0.8372 Student t-test). I) Representative TEM images 
of islet vessels cut en-face (scale bar: 1 µm). Boxed areas are enlarged (right). Arrows 
indicate fenestrations. J) Fenestrae diameter measurement shows no variation between virgin 
and G14.5 (n = 2 mice per condition, 100 fenestrae; P = 0.055 Student t-test). K) Fenestrae 
diameter measurement shows no variation after 2 weeks HFD (n = 2 mice per condition, 55-
115 fenestrae; P = 0.072 Student t-test).  
 
Figure 6. Inhibition of beta cell proliferation during gestation is not associated with 
altered permeability. V: virgin. TRP: tryptophan. A) Body weight of animals fed TRP+/- 
diet 6 days (n = 9-14 mice per condition; one-way ANOVA). B-C) IPGTT (2g/kg) (B) and 
analysis of AUC (C) (n = 6-7 mice per condition; one-way ANOVA). D) Representative 
confocal images of islets in virgin or G14.5 animals fed TRP- diet (scale: 100 µm, Z-
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projection of 11 µm stacks). E) Quantification of islet volume (n = 6 mice per condition; one-
way ANOVA). F) Representative labeling by Ki67 of nuclei in islets in virgin or G14.5 
animals fed TRP- diet. G) Quantification of Ki67+ nuclei in islets (n = 6 mice per condition; 
one-way ANOVA). H) Fluorescence variation in islets at two time points post i.v. injection of 
4 kDa dextran (virgin TRP-; top, G14.5 TRP-; bottom) (Scale: 100 µm). Tmax corresponds to 
time at which fluorescence intensity is maximum in the vessels. Green: FITC. Fluorescence 
variations were measured in regions of interest (blue dots). See also Movie S4. I) Molecule 
extravasation rate as a function of MW (n = 4-8 mice per condition; 1-2 movies/mouse; two-
way ANOVA). Values represent mean ± SEM. 
 
Figure 7. Measure of 2-NBDG uptake rate in vivo. A) Fluorescence variation in islets at 
three time points post i.m. injection of 2-NBDG (10 mg/kg) (virgin; top, G14.5; middle, HFD 
2 weeks; bottom) (Scale: 100 µm, Z-projection of 120 µm). Islets (circled) are easily 
identified by labeling of vessels with rhodamine-dextran (red). Green: 2-NBDG. See also 
Movie S5. B) Measurement of 2-NBDG fluorescence in islets over time post injection i.m.: 
normalized fluorescence profiles fitted with sigmoidal curves (left panel), and first derivatives 
of fitted sigmoidal curves (right panel) (n = 4-6 mice per condition, 1-2 islets/mouse; Mann-
Whitney test of inflexion points (left) and Vmax (right)). NF: normalized fluorescence, T: 
time. Values represent mean ± SEM. C) As for A), but fluorescence variation in islets at three 
time points post i.v. injection of 2-NBDG (5 mg/kg) (virgin; top, G14.5; middle, HFD 2 
weeks; bottom) (Scale: 100 µm, Z-projection of 120 µm). See also Movie S6. D) 
Measurement of 2-NBDG fluorescence in islets over time post injection i.v.: normalized 
fluorescence profiles fitted with one-phase association curves (n = 4-5 mice per condition, 1-2 
islets/mouse; Mann-Whitney test of inflexion points). Values represent mean ± SEM. 
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Figure 8. In vivo red blood cells velocity in islets is comparable between G14.5, 2 weeks 
HFD-fed and virgin animals. A) Still images extracted from movies of pancreatic blood 
flow in a virgin mouse acquired in vivo. See also Movie S7. Islet is circled. Bars indicate 
vessels selected for analysis. Grey: 150 kDa FITC-dextran. Image size: 274x274 µm. B) Red 
blood cell (RBC) velocity measured in exocrine tissue and islets in virgin, G14.5, and 2 week 
HFD-fed animals. Each dot represents an individual vessel (n = 5-6 animals per condition, 
one-way ANOVA). Data is represented as mean ± SEM. C) Blood glucose levels following 
ketamine/xylaxine anesthesia (n = 5-6 animals per condition, no significant difference, two-
way ANOVA). Data is represented as mean ± SEM. 
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Figure 1. In vivo molecule diffusion and extravasation in islets. V: Virgin. A-B) Schematic representation of 
the imaging setup: side view (A), ventral view (B). 1: tracheotomy, 2: jugular catheter, 3: heated saline 
perfusion, 4: temperature control. C) Fluorescence variation at three time points after i.v. injection of 4 kDa 
fluorescent dextran, in the exocrine tissue (top), and in islets (bottom; dashed circle) (Scale: 100 µm). 
Tmax corresponds to time at which fluorescence intensity is maximum in the vessels. Green: FITC. 
Fluorescence variations were measured in regions of interest (blue and red dots). See also Movie S1. D) 
Fluorescence intensity profiles over time post-injection of 4 kDa fluorescent dextran (AU) in vessels (red 
lines) and parenchyma (blue lines) of the endocrine (left) and exocrine (right) tissues. Lines correspond to 
times points at which pictures in (C) were taken. E) Molecule extravasation rate as a function of MW (n = 4-
8 mice per condition; 1-2 movies/mouse). F) Fluorescence decrease rate measured in tissue parenchyma, as 
a function of MW (n = 4-8 mice per condition; 1-2 movies/mouse, one-way ANOVA). Values represent mean 
± SEM.  
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Figure 2. Islet and beta cell modifications at G14.5 of gestation. A) Representative confocal images of islets 
in virgin animals and at G14.5 (scale bar: 50 µm, Z-projection of 16 µm stacks). B) Islet size is increased at 
G14.5 (n = 6 animals per condition; P<0.0005 Mann-Whitney test). C) Beta cells are hypertrophic at G14.5 
(n = 6 animals per condition; P<0.001 Mann-Whitney test). D-E) Basal insulin level is increased (n = 4-5 
mice per condition, P<0.05 Mann-Whitney test), while glucose-stimulated insulin secretion is unchanged at 
G14.5, as assessed by measurement of the increase in plasma insulin concentration post-glucose injection 
(3 g/kg) (e) (n = 4-5 mice per condition, two-way ANOVA). F) Representative confocal images of Ki67 
labeling in virgin animals and at G14.5 (same islets as in A) (scale bar: 50 µm, Z-projection of 16 µm 
stacks). G) Proliferation is increased at G14.5 (n = 6 animals per condition; P<0.001 Mann-Whitney test). 
H-I) IPGTT (2g/kg) in virgin and at G14.5 (H), and area under the curve (AUC) analysis (I) shows glucose 
intolerance at G14.5 (n = 6-8 animals per condition, P<0.01 Mann-Whitney test). Values represent mean ± 
SEM.  
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Figure 3. Glucose metabolism and beta cell proliferation are altered by 2 weeks of high fat diet. SD: 
standard diet, HFD: high fat diet. A) Body weight increase was larger in mice fed HFD (n = 18 mice per 
condition; two-way ANOVA). B) Randomly fed blood glucose levels were higher in HFD fed mice (n = 30 
mice per condition; two-way ANOVA). C-D) IPGTT (2g/kg) in SD and HFD fed animals (C), and area under 
the curve (AUC) analysis (D) shows glucose intolerance (n = 11 animals per condition, P<0.01 Mann-
Whitney test). E) Glucose-stimulated insulin secretion (3 g/kg) is not significantly decreased by 2 weeks 
HFD (n = 5 mice per condition, two-way ANOVA). F) Representative confocal images of islets in animals fed 
standard chow (SD) or HFD for 2 weeks (scale bar: 100 µm, Z-projection of 16 µm stacks). G) Islet size is 
not modified (n = 6 animals, 40-80 islets per condition; one-way ANOVA). H) Beta cells are hypertrophic at 
HFD 2 weeks (n = 6 animals per condition; P<0.001 Mann-Whitney test). I) Representative confocal images 
of Ki67 labeling in SD or HFD fed animals (scale bar: 100 µm, Z-projection of 16 µm stacks). J) Proliferation 
is increased following 2 weeks HFD feeding (n = 6 animals per condition; one-way ANOVA). Values 
represent mean ± SEM.  
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Figure 4. Modification of molecule diffusion in islets during metabolic demand. V: Virgin. HFD2w: High-fat-
diet 2 weeks. A) Fluorescence variation in an islet (dashed circle) at three time points after i.v. injection of 4 
kDa dextran at G14.5 of gestation (see also Movie S2) (Scale: 100 µm). Tmax corresponds to time at which 
fluorescence intensity is maximum in the vessels. Green: FITC. Fluorescence variations were measured in 
regions of interest (blue dots). Comparable images in virgin animals can be found in Fig. 1C. B) Molecule 
extravasation rate as a function of MW (n = 4-8 mice per condition; 1-2 movies/mouse) at G14.5. C) 
Fluorescence decrease rate in tissue parenchyma, as a function of MW at G14.5 (n = 4-9 mice per condition; 
1-2 movies/mouse; one-way ANOVA). D) Fluorescence variation in an islet (dashed circle) at three time 
points after i.v. injection of 4 kDa dextran following 2 weeks of HFD (see also Movie S3) (Scale: 100µm). 
Green: FITC. Fluorescence variations were measured in regions of interest (blue dots). E) Molecule 
extravasation rate as a function of molecular weight (n = 4-8 mice per condition; 1-2 movies/mouse) 
following 2 weeks of HFD. F) Fluorescence decrease rate in tissue parenchyma as a function of molecular 
weight (n = 4-9 mice per condition; 1-2 movies/mouse; one-way ANOVA) following 2 weeks of HFD. Values 
represent mean ± SEM.  
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Figure 5. Alterations to vessels in response to gestation and HFD. SD: standard diet, HFD: high fat diet. V: 
virgin. Values represent mean ± SEM. A-B) Representative confocal images of islet vasculature in virgin and 
gestating (G14.5) animals (A, left), and SD and HFD fed animals (B, left) (scale: 10 µm). Z-projections of 
26 (A) or 15 (B) µm stacks. Percentage of islet volume occupied by vessels (A-B, right panels) (n = 6 mice, 
3-10 islets per mouse; P<0.01 (A) and P = 0.19 (B); Student t-test). C) Representative transmission 
electron microscopy (TEM) images of islet vessels from virgin, G14.5 and HFD 2 weeks animals (scale: 10 
µm). D) Islet vessels lumen perimeter is increased at G14.5 compared to virgin animals (n = 2 mice, 14-17 
vessels per condition, P<0.01, Student t-test). E) Islet vessel lumen perimeter is unchanged in HFD 2 weeks 
compared to standard fed animals (n = 2 mice, 17-25 vessels per condition, P=0.11, Student t-test). F) 
Representative TEM images of islet vessels in virgin and G14.5 animals (scale: 1 µm). Boxed areas (left) are 
enlarged (right). Arrows indicate fenestrations. G) Density of fenestrations per µm of endothelium shows no 
variation between virgin and G14.5 (n = 2 mice per condition, 20-48 µm endothelium; P=0.2854 Student t-
test). H) Density of fenestrations is unchanged by HFD 2 weeks (n = 2 mice per condition, 25-48 µm 
endothelium; P = 0.8372 Student t-test). I) Representative TEM images of islet vessels cut en-face (scale 
bar: 1 µm). Boxed areas are enlarged (right). Arrows indicate fenestrations. J) Fenestrae diameter 
measurement shows no variation between virgin and G14.5 (n = 2 mice per condition, 100 fenestrae; P = 
0.055 Student t-test). K) Fenestrae diameter measurement shows no variation after 2 weeks HFD (n = 2 
mice per condition, 55-115 fenestrae; P = 0.072 Student t-test).  
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Figure 6. Inhibition of beta cell proliferation during gestation is not associated with altered permeability. V: 
virgin. TRP: tryptophan. A) Body weight of animals fed TRP+/- diet 6 days (n = 9-14 mice per condition; 
one-way ANOVA). B-C) IPGTT (2g/kg) (B) and analysis of AUC (C) (n = 6-7 mice per condition; one-way 
ANOVA). D) Representative confocal images of islets in virgin or G14.5 animals fed TRP- diet (scale: 100 
µm, Z-projection of 11 µm stacks). E) Quantification of islet volume (n = 6 mice per condition; one-way 
ANOVA). F) Representative labeling by Ki67 of nuclei in islets in virgin or G14.5 animals fed TRP- diet. G) 
Quantification of Ki67+ nuclei in islets (n = 6 mice per condition; one-way ANOVA). H) Fluorescence 
variation in islets at two time points post i.v. injection of 4 kDa dextran (virgin TRP-; top, G14.5 TRP-; 
bottom) (Scale: 100 µm). Tmax corresponds to time at which fluorescence intensity is maximum in the 
vessels. Green: FITC. Fluorescence variations were measured in regions of interest (blue dots). See also 
Movie S4. I) Molecule extravasation rate as a function of MW (n = 4-8 mice per condition; 1-2 
movies/mouse; two-way ANOVA). Values represent mean ± SEM.  
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Figure 7. Measure of 2-NBDG uptake rate in vivo. A) Fluorescence variation in islets at three time points 
post i.m. injection of 2-NBDG (10 mg/kg) (virgin; top, G14.5; middle, HFD 2 weeks; bottom) (Scale: 100 
µm, Z-projection of 120 µm). Islets (circled) are easily identified by labeling of vessels with rhodamine-
dextran (red). Green: 2-NBDG. See also Movie S5. B) Measurement of 2-NBDG fluorescence in islets over 
time post injection i.m.: normalized fluorescence profiles fitted with sigmoidal curves (left panel), and first 
derivatives of fitted sigmoidal curves (right panel) (n = 4-6 mice per condition, 1-2 islets/mouse; Mann-
Whitney test of inflexion points (left) and Vmax (right)). NF: normalized fluorescence, T: time. Values 
represent mean ± SEM. C) As for A), but fluorescence variation in islets at three time points post i.v. 
injection of 2-NBDG (5 mg/kg) (virgin; top, G14.5; middle, HFD 2 weeks; bottom) (Scale: 100 µm, Z-
projection of 120 µm). See also Movie S6. D) Measurement of 2-NBDG fluorescence in islets over time post 
injection i.v.: normalized fluorescence profiles fitted with one-phase association curves (n = 4-5 mice per 
condition, 1-2 islets/mouse; Mann-Whitney test of inflexion points). Values represent mean ± SEM.  
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Figure 8. In vivo red blood cells velocity in islets is comparable between G14.5, 2 weeks HFD-fed and virgin 
animals. A) Still images extracted from movies of pancreatic blood flow in a virgin mouse acquired in vivo. 
See also Movie S7. Islet is circled. Bars indicate vessels selected for analysis. Grey: 150 kDa FITC-dextran. 
Image size: 274x274 µm. B) Red blood cell (RBC) velocity measured in exocrine tissue and islets in virgin, 
G14.5, and 2 week HFD-fed animals. Each dot represents an individual vessel (n = 5-6 animals per 
condition, one-way ANOVA). Data is represented as mean ± SEM. C) Blood glucose levels following 
ketamine/xylaxine anesthesia (n = 5-6 animals per condition, no significant difference, two-way ANOVA). 
Data is represented as mean ± SEM.  
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SUPPLEMENTAL INFORMATION 
 
SUPPLEMENTAL FIGURES  
 
Figure S1 
Transgenic RIPTVA-mCherry mice present normal islet morphology and glucose 
tolerance. A) Representative confocal image of the vasculature in an islet. Z-projection of a 
70 µm stack. Red: mCherry, green: vessels (CD31) (scale: 100 µm). B) Reporter mCherry 
fluorescence is excluded from glucagon-positive cells and co-localizes with insulin-positive 
cells. Confocal images, Z-projections of 20 µm stacks, purple: glucagon, green: insulin, red: 
mCherry, blue: dapi (scale: 100 µm). C-D) IPGTT (2g/kg) in virgin C57BL/6J mice and 
RIPTVA-mCherry mice on a C57BL/6J background (C), and area under the curve (AUC) 
analysis (D) shows no glucose intolerance in transgenic mice (n = 5 animals per condition, 
P=0.4127, Mann-Whitney test). Values represent mean ± SEM. 
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 Figure S2 
Gestation-induced beta cell hypertrophy. A) Confocal images of islets from virgin and 
gestating mice (G14.5). Z-projection of a 16 µm stack. Red: insulin, green: vessels (CD31), 
purple: E-cadherin labeling of membranes (scale: 100 µm). Representative images shown. B) 
Enlargement of confocal images in (A) (scale: 30 µm). Z-projection of a 3 µm stack. Areas of 
insulin+ cells presenting a nuclei in cross-section were measured using ImageJ (Dapi staining 
in blue). C) Mean beta cell size, as measured in the images presented in (B) (P<0.001, Mann-
Whitney test). Values represent mean with range. D) Frequency distribution (fraction) of beta 
cell sizes measured in the images in (B). 
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 Figure S3 
Long-term high fat diet feeding (18 weeks) induces morphological changes to the islet 
vasculature. A) Representative confocal images of islet vasculature in standard diet (SD) and 
HFD diet-fed males (scale bar: 100 µm). Z-projections of 12 µm stacks. B) Quantification of 
capillary diameter show islet vessel dilation at 18 weeks of HFD diet feeding (n = 4 mice per 
condition; P<0.0001 One-way ANOVA). Values represent mean ± SEM. 
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Figure S4 
Structural and ultrastructural changes in islets of tryptophan-deprived gestating mice. 
A) Mean islet size is unchanged by gestation in TRP- conditions (n = 6 mice; P = 0.84, Mann-
Whitney test). Values represent mean with range. B) Relative frequency distribution of islet 
sizes in TRP- conditions shows an increase in the proportion of small and large islets at 
G14.5. C) Beta cell density in islets, measured as the number of insulin+ cells (presenting a 
nuclei in cross-section, stained with dapi) per islet surface unit, is reduced at G14.5 –TRP (n = 
3 mice, P < 0.01 Mann-Whitney test). D)  Beta cells are hypertrophic at G14.5 (n = 6 animals 
per condition; P < 0.001 Mann-Whitney test). E) Representative confocal images of islet 
vasculature in virgin and gestating (G14.5) animals fed TRP- diet (scale bar: 100 µm). Z-
projections of 11 µm stacks. F) Percentage of islet volume occupied by vessels (n = 6 mice; 
P<0.01 Student t-test). G) Density of fenestrations shows no variation between virgin and 
G14.5 fed TRP- diet (n = 2 mice, 22 to 57 µm total endothelium; P = 0.055 Student t-test 
test). H) Fenestrae diameter measurement shows no variation between virgin and G14.5 fed 
TRP- diet (n = 2 animals, 25-80 fenestrae; P = 0.87 Student t-test test). Values represent mean 
± SEM. 
 
 
Page 45 of 47 Diabetes
 Table S1. Summary of results according to condition. HFD: high fat diet, TRP-: 
tryptophan deficient diet, ND: not determined, +: increase, ++: large increase; +++: very large 
increase, 0: unchanged; -: small decrease; - -: large decrease.  
 G14.5 HFD 2 weeks G14.5 TRP- 
Glucose intolerance + + +++ 
Islet size +++ 0 0 
Vessel density + 0 + 
Beta cell 
proliferation 
+++ ++ 0 
Beta cell size +++ +++ +++ 
Islet blood cells 
velocity 
0 0 ND 
Vessel lumen 
perimeter 
+ 0 ND 
Fenestration 
diameter 
0 0 0 
Fenestration 
density 
0 0 0 
Permeability in 
islets 
- - - -  - - 
Molecule retention - - - - ND 
2-NBDG uptake - - -  ND 
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SUPPLEMENTAL MOVIES LEGENDS 
Movie S1 
In vivo diffusion of dextran-FITC molecules from the vasculature into the pancreatic 
parenchyma. Representative in vivo recordings following i.v. injection of 4-kDa dextran-
FITC and 70-kDa dextan-FITC, in exocrine tissue of a virgin female (left), or in an islet of a 
virgin female (right). Imaging was initiated at the time of i.v. injection of the fluorescent 
compound. Movie rate: 7 frames/s. Image size: 200×200µm (4-kDa) or 160x160µm (70kDa), 
single z-plane. Green: FITC. Fluorescence increases in the parenchyma following 4-kDa 
dextran injection but not following 70-kDa dextran injection. 
 
Movie S2 
In vivo diffusion of dextran-FITC molecules from the vasculature in islets of G14.5 
gestating animals. Representative in vivo recordings following i.v. injection of 4-kDa 
dextran-FITC and 70-kDa dextan-FITC, in exocrine tissue of a virgin female (left), or in an 
islet of a virgin female (middle), and in an islet of a gestating animal (G14.5 stage) (right). 
Imaging was initiated at the time of i.v. injection of the fluorescent compound. Movie rate: 7 
frames/s. Image size: 200×200µm (4-kDa) or 160x160µm (70kDa), single z-plane. Green: 
FITC. Fluorescence increases in the parenchyma following 4-kDa dextran injection but not 
following 70-kDa dextran injection. 
 
Movie S3 
In vivo diffusion of dextran-FITC molecules from the vasculature in islets of high fat 
diet-fed animals. Representative in vivo recordings following i.v. injection of 4-kDa dextran-
FITC and 70-kDa dextan-FITC in an islet of a standard fed female (left), or in an islet of a 2 
weeks female fed HFD for 2 weeks (right). Imaging was initiated at the time of i.v. injection 
of the fluorescent compound. Movie rate: 7 frames/s. Image size: 200×200µm, single z-plane. 
Green: FITC. Fluorescence increases in the parenchyma following 4-kDa dextran injection 
but not following 70-kDa dextran injection. 
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Movie S4 
In vivo diffusion of dextran-FITC molecules from the vasculature islets of tryptophan-
deprived animals. Representative in vivo recordings following i.v. injection of 4-kDa 
dextran-FITC in an islet of a virgin female (left), or in an islet of a gestating animal (G14.5 
stage; right), fed with tryptophan-deficient diet. Imaging was initiated at the time of i.v. 
injection of the fluorescent compound. Movie rate: 7 frames/s. Image size: 400×400µm, 
single z-plane. Green: FITC.  
 
Movie S5 
In vivo 2-NBDG uptake in islets following i.m. injection. Representative in vivo recordings 
following i.m. injection of 2-NBDG (5 mg/kg) in an islet of a virgin female (left), gestating 
animal (G14.5 stage; middle), and 2 weeks HFD-fed female (right). Imaging was initiated 1 
min post i.m. injection of the fluorescent compound. Total elapsed time: 32.5 min. Image size: 
300×300µm, 120µm z-projection. Green: 2-NBDG.  
 
Movie S6 
In vivo 2-NBDG uptake in islets following i.v. injection. Representative in vivo recordings 
following i.v. injection of 2-NBDG (10 mg/kg) in an islet of a virgin female (left), gestating 
animal (G14.5 stage; middle), and 2 weeks HFD-fed female (right). Imaging was initiated 15s 
prior to i.v. injection of the fluorescent compound. Total elapsed time: 15.25 min. Image size: 
300×300µm, 120µm z-projection. Green: 2-NBDG.  
 
Movie S7 
Red blood cells velocity in islets in vivo. Representative in vivo recordings of blood flow 
following i.v. injection of 150-kDa dextran-FITC, in an islet of a virgin (left), gestating 
animal (G14.5 stage, middle), and 2 weeks HFD-fed female (right). Islets are circled. Movie 
rate: 30 frames/s. Four frames out of 5 have been cut out of the original movies (original 
movies rate: 150 frames/s). Total elapsed time 6.6 s. Image size: 274×314µm, each movie. 
Single z-planes. Grey: FITC.  
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